Literature DB >> 22736929

Surgical resection of a solitary para-aortic lymph node metastasis from hepatocellular carcinoma.

Junji Ueda1, Hiroshi Yoshida, Yasuhiro Mamada, Nobuhiko Taniai, Sho Mineta, Masato Yoshioka, Youichi Kawano, Tetsuya Shimizu, Etsuko Hara, Chiaki Kawamoto, Keiko Kaneko, Eiji Uchida.   

Abstract

Lymph node (LN) metastases from hepatocellular carcinoma (HCC) are considered uncommon. We describe the surgical resection of a solitary para-aortic LN metastasis from HCC. A 65-year-old Japanese man with B-type liver cirrhosis was admitted for the evaluation of a liver tumor. He had already undergone radiofrequency ablation, transcatheter arterial chemoembolization, and percutaneous ethanol injection therapy for HCC. Despite treatment, viable regions remained in segments 4 and 8. We performed a right paramedian sectionectomy with partial resection of the left paramedian section of the liver. Six months later, serum concentrations of alpha-fetoprotein (189 ng/mL) and PIVKA-2 (507 mAU/mL) increased. Enhanced computed tomography of the abdomen revealed a tumor (20 mm in diameter) on the right side of the abdominal aorta. Fluorine-18 fluorodeoxyglucose positron emission tomography revealed an increased standard uptake value. There was no evidence of recurrence in other regions. Esophagogastroduodenoscopy and colonoscopy revealed no malignant tumor in the gastrointestinal tract. Para-aortic LN metastasis from HCC was thus diagnosed. We performed lymphadenectomy. Histopathological examination revealed that the tumor was largely necrotic, with poorly differentiated HCC on its surface, which confirmed the suspected diagnosis. After 6 mo tumor marker levels were normal, with no evidence of recurrence. Our experience suggests that a solitary para-aortic LN metastasis from HCC can be treated surgically.

Entities:  

Keywords:  Hepatectomy; Hepatocellular carcinoma; Lymph node metastasis; Positron emission tomography; Surgical resection

Mesh:

Year:  2012        PMID: 22736929      PMCID: PMC3380333          DOI: 10.3748/wjg.v18.i23.3027

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Estimating the world cancer burden: Globocan 2000.

Authors:  D M Parkin; F Bray; J Ferlay; P Pisani
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

Review 2.  Hepatic lymphatic system: structure and function.

Authors:  S Magari
Journal:  J Gastroenterol Hepatol       Date:  1990 Jan-Feb       Impact factor: 4.029

3.  A case of recurring hepatocellular carcinoma with a solitary Virchow's lymph node metastasis.

Authors:  Nobuhiko Taniai; Hiroshi Yoshida; Yasuhiro Mamada; Yoshiaki Mizuguchi; Takeo Fujihira; Koho Akimaru; Takashi Tajiri
Journal:  J Nippon Med Sch       Date:  2005-08       Impact factor: 0.920

Review 4.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

5.  Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases.

Authors:  J Watanabe; O Nakashima; M Kojiro
Journal:  Jpn J Clin Oncol       Date:  1994-02       Impact factor: 3.019

6.  Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment.

Authors: 
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

7.  Skip lymph node metastases from a small hepatocellular carcinoma with difficulty in preoperative diagnosis.

Authors:  Keisuke Uehara; Hiroshi Hasegawa; Seiji Ogiso; Eiji Sakamoto; Syusaku Ohira; Tsuyoshi Igami; Toshiharu Mori
Journal:  J Gastroenterol Hepatol       Date:  2003-03       Impact factor: 4.029

8.  Sentinel lymph node biopsy and axillary staging of T1-T2 N0 breast cancer: a multicenter study.

Authors:  S Sandrucci; A Mussa
Journal:  Semin Surg Oncol       Date:  1998-12

9.  Treatment of lymph node recurrence in patients with hepatocellular carcinoma.

Authors:  Y Une; K Misawa; T Shimamura; K Ogasawara; Y Masuko; N Sato; Y Nakajima; J Uchino
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

10.  18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.

Authors:  Masahiro Sugiyama; Harumi Sakahara; Tatsuo Torizuka; Toshihiko Kanno; Fumitoshi Nakamura; Masami Futatsubashi; Satoshi Nakamura
Journal:  J Gastroenterol       Date:  2004-10       Impact factor: 7.527

View more
  6 in total

1.  Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma.

Authors:  Michael L Caparelli; Nathan J Roberts; Timothy S Braverman; Robert M Stevens; Edward R Broun; Shyam Allamaneni
Journal:  World J Hepatol       Date:  2016-08-18

2.  Pancreaticoduodenectomy for hepatic portal lymph node metastasis after hepatic resection for hepatocellular carcinoma: A clinical case report.

Authors:  Tran Que Son; Tran Hieu Hoc; Vu Duc Long; Nguyen Toan Thang; Tran Thu Huong; Pham Van Tuyen
Journal:  Int J Surg Case Rep       Date:  2021-04-27

3.  Solitary Metastasis to a Distant Lymph Node in the Descending Mesocolon After Primary Resection for Hepatocellular Carcinoma: Is Surgical Resection Valid?

Authors:  Yuki Aisu; Hiroaki Furuyama; Tomohide Hori; Takafumi Machimoto; Toshiyuki Hata; Yoshio Kadokawa; Shigeru Kato; Yasuhisa Ando; Yuichiro Uchida; Daiki Yasukawa; Yusuke Kimura; Maho Sasaki; Yuichiro Takamatsu; Tunehiro Yoshimura
Journal:  Am J Case Rep       Date:  2016-12-01

4.  Primary hepatic carcinosarcoma with multimodal treatment.

Authors:  Daisuke Kurita; Yasuji Mokuno; Hideo Matsubara; Hirokazu Kaneko; Mikihiro Shamoto; Akira Satou; Shinsuke Iyomasa
Journal:  Nagoya J Med Sci       Date:  2018-08       Impact factor: 1.131

5.  Hoarseness due to lymph node metastasis of hepatocellular carcinoma: A case report.

Authors:  Lin Xu; Feng Xue; Boqing Wang; Dong Yan; Wei Ding; Jiwei Yin; Chao Yi; Wei Wang
Journal:  Oncol Lett       Date:  2016-06-08       Impact factor: 2.967

Review 6.  Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation.

Authors:  Marco Biolato; Tiziano Galasso; Giuseppe Marrone; Luca Miele; Antonio Grieco
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.